About Nancy Cass
Form D filings for Biocurity Pharmaceuticals from 2016 to 2023 list Nancy Cass as director.
Nancy Cass first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Nancy Cass in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Nancy Cass works with at each company, as listed on that company's latest Form D.
Biocurity Pharmaceuticals Inc. · Form D, Jun 21, 2023
SM
Sam Merchant
Director
CB
Cheryl Baker
Secretary and Treasurer, director